012790 Stock Chart & Stats
₩5130.00
-₩100.00(-1.91%)
―
--
Day’s Range― - ―
52-Week Range₩4,820.00 - ₩6,820.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)21.43K
Market Cap
₩60.46B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)8.7
Beta0.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,986,415
10 Day Avg. Volume14,482
30 Day Avg. Volume21,431
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
012790 FAQ
What was SINIL PHARMACEUTICAL Co., Ltd.’s price range in the past 12 months?
SINIL PHARMACEUTICAL Co., Ltd. lowest stock price was ₩4820.00 and its highest was ₩6820.00 in the past 12 months.
What is SINIL PHARMACEUTICAL Co., Ltd.’s market cap?
SINIL PHARMACEUTICAL Co., Ltd.’s market cap is ₩60.46B.
When is SINIL PHARMACEUTICAL Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SINIL PHARMACEUTICAL Co., Ltd.’s earnings last quarter?
SINIL PHARMACEUTICAL Co., Ltd. released its earnings results on May 15, 2026. The company reported ₩124.246 earnings per share for the quarter, beating the consensus estimate of N/A by ₩124.246.
Is SINIL PHARMACEUTICAL Co., Ltd. overvalued?
According to Wall Street analysts SINIL PHARMACEUTICAL Co., Ltd.’s price is currently Undervalued.
Does SINIL PHARMACEUTICAL Co., Ltd. pay dividends?
SINIL PHARMACEUTICAL Co., Ltd. does not currently pay dividends.
What is SINIL PHARMACEUTICAL Co., Ltd.’s EPS estimate?
SINIL PHARMACEUTICAL Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SINIL PHARMACEUTICAL Co., Ltd. have?
SINIL PHARMACEUTICAL Co., Ltd. has 11,986,415 shares outstanding.
What happened to SINIL PHARMACEUTICAL Co., Ltd.’s price movement after its last earnings report?
SINIL PHARMACEUTICAL Co., Ltd. reported an EPS of ₩124.246 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.349%.
Which hedge fund is a major shareholder of SINIL PHARMACEUTICAL Co., Ltd.?
Currently, no hedge funds are holding shares in KR:012790
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sinsin Pharmaceutical Co., Ltd.
―
Samik Pharm Co., Ltd.
―
GL Pharm Tech Corp.
―
PanGen Biotech, Inc.
―
KoBioLabs, Inc.
―